GlassScriptPhysician profile
John Y Lee
NPI 1568648608
$8,342.89
in general payments reported to CMS, 2019-2025
23 companies · $2,291 in 2025
The $2,291 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,043 · 2020: $492 · 2021: $566 · 2022: $1,350 · 2023: $1,386 · 2024: $1,214 · 2025: $2,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,683 · Travel and Lodging: $1,208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,683.32 |
| Travel and Lodging | $1,207.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,241.23 | 2021-2025 | Interstim |
| Abbott Laboratories | $1,252.88 | 2025 | Amplatzer Talisman |
| Teleflex LLC | $1,136.50 | 2022-2025 | Urolift, Barrigel |
| Medtronic USA, INC. | $818.52 | 2019-2020 | |
| Astellas Pharma US INC | $331.38 | 2019-2022 | |
| Boston Scientific Corporation | $255.31 | 2019-2025 | Solyx Sis System, Lithovue |
| Abbvie INC. | $204.06 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $178.07 | 2023 | Prolaris |
| Sumitomo Pharma America, INC. | $162.58 | 2024-2025 | Gemtesa |
| Neotract INC. | $154.61 | 2019-2020 | |
| Janssen Biotech, INC. | $126.72 | 2019 | |
| Pfizer INC. | $99.85 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $77.70 | 2019-2023 | Xiaflex |
| Procept Biorobotics Corporation | $67.88 | 2024 | Aquabeam System |
| Siemens Medical Solutions USA, INC. | $50.63 | 2023 | Corpath Imaging System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $39.63 | 2019-2020 | |
| Coopersurgical, INC. | $34.96 | 2020-2021 | |
| Dendreon Pharmaceuticals LLC | $26.29 | 2019 | |
| Olympus America INC. | $23.08 | 2025 | Soltive |
| C. R. Bard, INC. & Subsidiaries | $22.19 | 2024 | Bard Urinary Drainage Bag |
| 180 Medical, INC. | $14.05 | 2022 | |
| Ethicon US, LLC | $12.74 | 2020 | |
| Coloplast Corp | $12.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.